- Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line hormonal treatment. Swiss Group for Clinical Cancer Research (SAKK). Bernhard, J., Castiglione-Gertsch, M., Schmitz, S.F., Thürlimann, B., Cavalli, F., Morant, R., Fey, M.F., Bonnefoi, H., Goldhirsch, A., Hürny, C. Eur. J. Cancer (1999)